These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease. Férnandez-Calle P; Molina JA; Jiménez-Jiménez FJ; Vázquez A; Pondal M; García-Ruiz PJ; Urra DG; Domingo J; Codoceo R Neurology; 1992 May; 42(5):1064-6. PubMed ID: 1579230 [TBL] [Abstract][Full Text] [Related]
11. Serum levels of vitamin A in Parkinson's disease. Jiménez-Jiménez FJ; Molina JA; Fernández-Calle P; Vázquez A; Pondal M; del Ser T; Gómez-Pastor A; Codoceo R J Neurol Sci; 1992 Aug; 111(1):73-6. PubMed ID: 1403000 [TBL] [Abstract][Full Text] [Related]
12. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers. Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079 [TBL] [Abstract][Full Text] [Related]
13. [Serum pro-oxidant and antioxidant factors and risk of Parkinson's disease: population study]. Molina-Arjona JA; de Bustos F; Benito-León J; Jiménez-Jiménez FJ; Rodríguez J; Trincado R; Porta-Etessan J; Vega S; Bermejo F Rev Neurol; 1999 Jul 1-15; 29(1):12-5. PubMed ID: 10528302 [TBL] [Abstract][Full Text] [Related]
14. Correlations between abnormal iron metabolism and non-motor symptoms in Parkinson's disease. Xu W; Zhi Y; Yuan Y; Zhang B; Shen Y; Zhang H; Zhang K; Xu Y J Neural Transm (Vienna); 2018 Jul; 125(7):1027-1032. PubMed ID: 29748849 [TBL] [Abstract][Full Text] [Related]
15. The serum ferrokinetics in Parkinson's disease. Chen WH; Shih PY Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Nov; 8(11):581-4. PubMed ID: 1296037 [TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease. Jiménez-Jiménez FJ; Molina JA; Aguilar MV; Meseguer I; Mateos-Vega CJ; González-Muñoz MJ; de Bustos F; Martínez-Salio A; Ortí-Pareja M; Zurdo M; Martínez-Para MC J Neural Transm (Vienna); 1998; 105(4-5):497-505. PubMed ID: 9720977 [TBL] [Abstract][Full Text] [Related]
17. Parkinson's Disease is Accompanied by Intertwined Alterations in Iron Metabolism and Activated Immune-inflammatory and Oxidative Stress Pathways. de Farias CC; Maes M; Bonifacio KL; Matsumoto AK; Bortolasci CC; Nogueira AS; Brinholi FF; Morimoto HK; de Melo LB; Moreira EG; Barbosa DS CNS Neurol Disord Drug Targets; 2017; 16(4):484-491. PubMed ID: 28240188 [TBL] [Abstract][Full Text] [Related]
18. Lower hemoglobin levels in patients with parkinson's disease are associated with disease severity and iron metabolism. Deng Q; Zhou X; Chen J; Pan M; Gao H; Zhou J; Wang D; Chen Q; Zhang X; Wang Q; Xu Y Brain Res; 2017 Jan; 1655():145-151. PubMed ID: 27840188 [TBL] [Abstract][Full Text] [Related]
19. Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson's disease. Si QQ; Yuan YS; Zhi Y; Tong Q; Zhang L; Zhang K Neurosci Lett; 2018 Sep; 684():42-46. PubMed ID: 29981876 [TBL] [Abstract][Full Text] [Related]